Small Caps Can Continue to Rally But Needs Deal Flow…Update-3
Licensing and M&A Through the JPM Meeting in Early January 2024 Should Support Gains Update-3 12/22 ,,,Added Catalyst (Pharmaceuticals (CPRX)at 16+, is focused on rare neurological and epileptic diseases. Karuna Therapeutics (KRTX) up 47% to $316 handle on Bristol Myers (BMY) $14B buyout...
Biotech is Coming Back, Can the Run Last ?-Update-3…
Update-3 12/15 2P EDT. Crazy week so take some profits. Update-2 ...12/13/23... Dont fight the tape as momentum rally continues with a little help from the FED. Broad rally takes all indices up over 1.3% with small cap Russell 2000 (IWM) up 3.39%! Biotechs very strong with IBB up 4.18% to...
Can Small Cap Biotech Stocks Continue to Run? Let’s take a look…Update-3…momentum continues
Biden vs Biopharmaceutical industry: "March in on Patents".. https://x.com/PeterKolchinsky/status/1732852724675273103?s=2 Will the Administration take back licensing rights with government funded research to control drug prices? ======= ASH this past week. Update-3 JY 8- 10:40a....Biotech...
Biotech and Healthcare Portfolio Playbook for December 2023/24…Update-3…XBI spikes
12/3...We will focus on SMID cap stocks in the coming week as tracked by the XBI with resistance at $80. Also track health care providers (IHF) in light of Cigna/ Human merger potential and UNH as the dominant player. Update-2 ...XBI is cruising to $77 handle up 3% on Friday, IBB up 2.71% for...
Are you a Trader or Investor: Biotech Momentum Is Picking Up…Update-1
Update-1 11/22...Another good day but as the S&P 500 approaches 4,600 we are near the top of the range from Aug 1, when the recent sell-off began. The QQQ hit a new high at 390 exceeding the JUL 19 high of 385. Small cap biotechs that we track continue to have within day volatility masking...